Njord Medtech® is pleased to announce the appointment of Frank Koall as Commercial Director, as Njord targets to further accelerate commercial growth.
As Commercial Director DACH, Frank will take office on 1 January 2023 and lead the commercial efforts in the DACH region. Mr. Koall comes to Njord Medtech with deep experience in international sales and management working for start-ups, SMEs, and multinationals.
Recently he held the position as Chief Commercial Officer for CAScination in Switzerland, a company specialised in cancer treatment via interventional radiology. His passion for implementing new treatment pathways and technologies within the healthcare industry includes active implants, a large variety of investment goods, consumables, and SaaS.
"It is fantastic that we can expand our competence with Frank in our team. His experience in building and leading commercial growth initiatives across European markets is a great fit for Njord and our strategic plan going forward. With Frank’s passion and knowledge, we’re set on a trajectory to alter the working environment and related patient handling of many radiology nurses within the DACH region" commented Jacob Ahrnstein, CEO Njord Medtech.
Njord Medtech® is set on a mission to bring forward new solutions for a value- and a patient-centric healthcare system. The company has been incubated within the Sahlgrenska University Hospital since 2017 and incorporated in 2019. Founded by Barbro Cagner - former nurse, union representative, and deputy head at Sahlgrenska Radiology. Njord Medtech continuously strives to solve the unmet needs of patients, caregivers, and doctors to improve the quality of care.